If AI 2027 is right, are we really going to make patients wait 15 years for treatments that will soon exist?

The advent of AI systems by 2027 could dramatically accelerate biomedical research, leading to new treatments. However, current validation, regulation, and deployment processes, which often delay medications for 10-15 years, are unprepared for this rapid pace. This raises concerns about patients waiting extended periods for potentially life-changing treatments that could be available much sooner if these bottlenecks are addressed.

This discussion moves the AI bottleneck from scientific discovery to validation and regulation, unlike earlier concerns focused on research capabilities.